- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00198965
Olestra Containing Foods and Weight Loss and Weight Maintenance
Benefits of Sensory-Enhanced Products in Weight Loss and Maintenance
Study Overview
Status
Conditions
Detailed Description
During Phase I, the three groups will attend mandatory, 1 hour, bi-weekly group meetings. Participants will keep food records for 2 weekdays and 1 weekend day during each 2 week period as well as keeping exercise, snack and sleep logs daily. At each meeting, research staff will collect the completed food records and logs and new forms will be distributed. At weeks 8 and 16 of active weight loss, participants will repeat the assessments (blood tests, body composition, and questionnaires) conducted at baseline to determine treatment-induced changes in each of the dependent measures.
During phase II, all of the groups will participate in group meetings held 1 month after beginning maintenance and quarterly over 52 weeks. Dependent upon group, participants will pick-up foods bi-weekly and body weight will be assessed every 4 weeks. The full battery of assessments will be conducted at 26 weeks and at the end of the maintenance phase at 52 weeks.
Participants will be 180 adults (male and female) between 25 and 50 years of age. The study is designed to answer questions involving an adult population. Participants must be interested in losing weight. Participants must have a body mass index between 30 and 33 because this study is designed to answer questions investigating overweight individuals that are not morbidly obese. Participants with preliminary eligibility, determined via phone screening, will be invited to the clinic for a more in-depth screening including demographic and medical history questionnaires and psychosocial measures. Participants will gibe their consent to provide this information via completing a screening consent form (a separate form from the study consent form). Once this secondary eligibility is determined, a study consent form will be completed, and participants will undergo a baseline screening of physical measures, blood tests (CBC, SMA-20), body composition assessment (via bioelectrical impedance), and complete additional psychosocial questionnaires. Any participants found to be ineligible as a result of these measures will not be permitted to continue in the study, but will be referred for medical care if appropriate. Participants deemed eligible will proceed to the weight loss phase.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Lutherville, Maryland, United States, 21093
- Johns Hopkins University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
male and female, between 25 and 50 years of age, interested in losing weight, body mass index between 30 and 33, informed consent
Exclusion Criteria:
unwilling to eat study provided foods
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
weight
|
body composition
|
blood values
|
Secondary Outcome Measures
Outcome Measure |
---|
blood pressure
|
pulse
|
psychometrics
|
waist/hip measurements
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Lawrence J Cheskin, MD, Johns Hopkins Bloomberg School of Public Health
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PG1999-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on dietary education
-
King's College LondonRecruitingInflammatory Bowel Diseases | Crohn DiseaseUnited Kingdom
-
Ajou University School of MedicineCompletedHyperphosphatemia | End-stage Renal Disease
-
University of California, DavisAcademy of Nutrition and DieteticsActive, not recruitingKidney Diseases | Hypertension | Obesity | Diabetes | Diet, Healthy | Kidney Transplant; Complications | Lifestyle, Healthy | Transplant;Failure,KidneyUnited States
-
Samsung Medical CenterRecruitingGastric Cancer | GastrectomyKorea, Republic of
-
Unity Health TorontoCompletedChronic Kidney DiseaseCanada
-
University of ManitobaThe Lawson Foundation; Public Health Agency of Canada (PHAC)RecruitingObesity | Type 2 Diabetes | Gestational DiabetesCanada
-
University of RochesterRochester Lifestyle Medicine InstituteCompletedChronic Kidney DiseasesUnited States
-
DongGuk UniversityMinistry of Food and Drug Safety, KoreaUnknownHypertension | PrehypertensionKorea, Republic of
-
University of PretoriaSouth African Sugar AssociationCompletedType 2 Diabetes MellitusSouth Africa